SOURCE: Cerora, Inc.

Cerora, Inc.

May 30, 2014 12:35 ET

Cerora, Inc. Introduces Qumpass™ Neuropsychological Testing Software at Meeting of American College of Sports Medicine (ACSM)

Software Uniquely Supports Both 'Return-to-Learn' and 'Return-to-Play' Decisions Around Concussion

ORLANDO, FL--(Marketwired - May 30, 2014) -  Noting that school athletes who've sustained a concussion are at magnified risk if they return to the playing field too soon, Cerora, Inc. today continued its introduction of Qumpass™ brain evaluation software to help empower clinicians to objectively assess that risk. Qumpass has been specifically designed to enable clinicians to address the equally important, if not more important, 'Return-to-Learn' question -- because returning to class without a significant period of cognitive rest can put a patient at substantial risk.

Cerora's Qumpass software is the first in a series of new Cerora products aimed at finally providing coaches and sports medicine practitioners with objective criteria for their decisions on whether players are ready to resume sports, studies, or other brain-intensive challenges.

"Cognitive rest is an often neglected component of concussion management, yet is as vital to an athlete's recovery as physical rest" stated Jack Foley, Assistant Athletic Director and Director of Sports Medicine at Lehigh University. "Lehigh's therapeutic goal is to limit cognitive (concentration, learning, memory) activity to a level that is tolerable and does not exacerbate the re-emergence of symptoms. Our mantra is "Cognitive management = Academic management!" 

"We've designed our new Qumpass software precisely to address the need for cognitive data that would inform the concussion-related decisions that sports clinicians like Jack Foley deal with daily", commented Cerora CEO, Adam Simon, PhD. "In addition to Qumpass, we are working closely with Jack and Lehigh Sports Medicine to evaluate the addition of our new MindReader™ wearable EEG/biosensor device to his trainer's kit of available tools."

Sports medicine clinicians are invited to learn more about Qumpass and Cerora's developing product pipeline by visiting exhibit booth number 347 at the ACSM meeting.

About Lehigh University & Lehigh Sports Medicine

Lehigh University is a highly ranked, world-class research institution located in Bethlehem, Pennsylvania which provides an interdisciplinary educational experience for some of the best and brightest scholars. Under the direction of Jack Foley, Lehigh Sports Medicine has 7 Athletic Trainers with over 50 years combined experience who work independently and interdependently to provide prevention, care, and rehabilitation for the over 600 student-athletes participating in 25 Division-1 intercollegiate athletic teams within the Patriot League. 

Over the past fifteen years, Lehigh Sports Medicine has continued to be a leader in the areas of skin infection prevention and management, concussion prevention and management, injury prevention programming, environmental policies, recruit medical screening, and student-athlete education. As a result of their excellent reputation and cutting edge approach, Jack Foley and his staff have been afforded the opportunity to participate in several ground breaking clinical research studies.

About Cerora, Inc.

Cerora is leading the way in the development and testing of software and hardware technologies required to provide critically important, objective, portable biomarker-based brain-function diagnostic information. Located in the high-tech nexus at Ben Franklin Technology Partners of Northeastern Pennsylvania's TechVentures on Lehigh University's Mountaintop Campus in Bethlehem, Pennsylvania, the company has assembled a team of experienced medical scientists and management professionals under the leadership of CEO Adam J. Simon, PhD, a noted physicist and globally-recognized brain biomarker expert.

For additional information please visit www.cerora.com

Contact Information